{"id":"NCT00674661","sponsor":"Glaukos Corporation","briefTitle":"Corneal Collagen Cross-Linking for Ectasia (CXL)","officialTitle":"Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-12","primaryCompletion":"2011-11","completion":"2011-11","firstPosted":"2008-05-08","resultsPosted":"2017-01-27","lastUpdate":"2021-04-26"},"enrollment":130,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Ectasia"],"interventions":[{"type":"DRUG","name":"riboflavin ophthalmic solution","otherNames":[]},{"type":"DEVICE","name":"UVA Irradiation","otherNames":["UV-Xâ„¢ Illumination System"]}],"arms":[{"label":"Corneal Collagen Cross-linking (CXL) Treatment Group","type":"ACTIVE_COMPARATOR"},{"label":"Control Group","type":"SHAM_COMPARATOR"}],"summary":"Prospective, randomized multicenter study to determine the safety and effectiveness of performing corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes with ectasia after refractive surgery.","primaryOutcome":{"measure":"Mean Change From Baseline in Maximum Keratometry (Kmax)","timeFrame":"baseline,12 months","effectByArm":[{"arm":"Corneal Collagen Cross-linking (CXL) Treatment Group","deltaMin":-0.5,"sd":2.2},{"arm":"Control Group","deltaMin":0.5,"sd":2.3}],"pValues":[]},"eligibility":{"minAge":"14 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":2},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":["22692521"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":67},"commonTop":["Corneal opacity","Eye pain","Corneal epithelium defect","Punctate keratitis","Vision blurred"]}}